Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
CLEVELAND, May 05, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the three months ended March 31, 2016. Highlights of the first quarter of 2016 and...
-
CLEVELAND, April 18, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its first quarter 2016 financial results at approximately 4:00 PM EDT on Thursday, May 5, 2016, and host a...
-
CLEVELAND, March 18, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present at the Alliance for Regenerative Medicine’s 4th...
-
CLEVELAND, March 10, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the fourth quarter and year ended December 31, 2015. “Overall, we have made...
-
TOKYO, Feb. 18, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (“Athersys”) (Nasdaq:ATHX) today announced positive results from the analysis of one-year follow-up data from its Phase 2 clinical study of...
-
CLEVELAND, Feb. 17, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced positive results from the analysis of one-year follow-up data from its Phase 2 clinical study of the...
-
CLEVELAND, Feb. 17, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced positive results from the analysis of one-year follow-up data from its Phase 2 clinical study of the...
-
CLEVELAND, Feb. 10, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that six presentations featuring Athersys’ MultiStem® cell therapy treatment for ischemic stroke will be...
-
CLEVELAND, Feb. 09, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its year end 2015 financial results at approximately 4:00 PM EST on Thursday, March 10, 2016, and host a...
-
CLEVELAND, Feb. 01, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it will present at the 18th annual BIO CEO & Investor Conference to be held on February 8-9, 2016...